Pygeum bark is one of the most widely studied herbs for benign prostatic hyperplasia (BPH) and is approved as a pharmaceutical preparation in France and other European countries. Its phytosterols and triterpenes reduce prostate inflammation, inhibit prostate cell proliferation, and improve urinary flow and nocturia. It is harvested from the African plum tree — an endangered species due to overharvesting, so sources should be certified sustainable.
bark
standardised extract, capsule, tincture
100–200mg standardised bark extract daily; or 50mg 2× daily; best results with consistent use over 6–8 weeks
Generally well tolerated. May cause mild GI upset — take with food. Source from sustainably certified suppliers only. Limited data in pregnancy and breastfeeding.
Explore the full cross-tradition profile, AI botanical notes, and related blends:
Open Pygeum in the app →